JA

Joao Amorim

Manager, Business Development & Licensing at Mass General Brigham Innovation

Boston, Massachusetts

Overview 

Joao Amorim is a Healthcare Innovation & Business Development professional based in Boston, Massachusetts, currently serving as a Manager of Business Development & Licensing at Mass General Brigham Innovation. With a background in biochemistry and extensive experience at prestigious institutions like Harvard Medical School and Harvard Business School, Joao has a proven track record in driving successful collaborations and investments within the pharmaceuticals, digital health, and biotech sectors. Having completed a Mini-MBA at Harvard Business School and holding a Doctor of Philosophy in Experimental Biology and Biomedicine, Joao has excelled in roles such as Postdoctoral Fellow at Harvard Medical School and Analyst at Catalio Capital Management and Apollo Health Ventures. His expertise in cell culture, oxidative stress, and research has enabled him to make significant contributions to the healthcare innovation landscape.

Work Experience 

MG

Mass General Brigham Innovation

  • Manager, Business Development & Licensing

    2024 - Current

  • Associate, Business Development & Licensing

    2023 - 2024

HM

Harvard Medical School

  • Postdoctoral Fellow

    2020 - 2023

    - Investigating the role of epigenetic alterations in a mouse genome responsible for the early onset of age-related phenotypes and related diseases

  • PhD Candidate

    2017 - 2019

    - Investigating a novel mechanism by which small molecules activate SIRT1 and how they can be used to treat aging and age-related metabolic diseases

CC

Catalio Capital Management

  • Analyst

    2021 - 2022

    - Performed scientific and investment diligence on biotech companies across multiple therapeutic areas - Contributed to multiple investment memos highlighting the investment thesis of prospective companies, including technical, regulatory, market, financial and intellectual property analysis - Performed deal sourcing by engaging with companies' management teams through introductory calls and investment conferences

Catalio Capital Management is a venture capital firm that invests in breakthrough biomedical technology companies.

cataliocapital.com
AH

Apollo Health Ventures

  • Analyst

    2020 - 2021

    - Prepared risk analyses and mitigation/diligence plans to evaluate early-stage investment opportunities in mitochondria physiology - Identified and prioritize potential programs for pre-seed and seed-stage through in-depth literature review, KOL engagement, and risk analyses

HB

Harvard Business School

  • Lab to Market, MBA classes

    2019 - 2019

    - Assessed commercial opportunities for a vectored antibody delivery technology developed in the Balazs Lab at The Ragon Institute - Identified and defined the TPP for target disease indications, assessed IP, evaluated go-to-market strategy for different indications, defined the regulatory strategy

Ud

Universidade de Coimbra

  • MSc Student

    2013 - 2014

    - Studied the impact of mitochondria dysfunction pre-synaptic nerve terminals in an in vitro model of Alzheimer's disease

Education 

Articles About Joao

Relevant Websites